Diamant Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.07B Buy
1,070,612
+1,069,720
+119,924% +$1.08B 0.78% 27
2025
Q4
$959K Sell
892
-22
-2% -$21K 0.69% 28
2025
Q3
$697K Buy
914
+100
+12% +$74.4K 0.51% 38
2025
Q2
$635K Hold
814
0.48% 41
2025
Q1
$672K Hold
814
0.51% 42
2024
Q4
$628K Buy
814
+14
+2% +$11.6K 0.4% 45
2024
Q3
$709K Hold
800
0.44% 44
2024
Q2
$724K Hold
800
0.48% 43
2024
Q1
$622K Hold
800
0.43% 46
2023
Q4
$466K Hold
800
0.35% 52
2023
Q3
$430K Hold
800
0.35% 50
2023
Q2
$375K Hold
800
0.29% 56
2023
Q1
$275K Hold
800
0.23% 61
2022
Q4
$293K Buy
+800
New +$284K 0.26% 58

Other funds holding LLY

Diamant Asset Management's LLY Position: Q1 2026 in Review

Diamant Asset Management increased its Eli Lilly (LLY) stake by 119,924% in Q1 2026, buying an estimated $1.08B and bringing the position to 1,070,612 shares worth $1.07B. The position accounts for 0.78% of the portfolio, ranked #27.

Diamant Asset Management first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Diamant Asset Management held 1,070,612 shares of Eli Lilly worth $1.07B as of Q1 2026.
  • Diamant Asset Management bought 1,069,720 Eli Lilly shares in Q1 2026, an estimated $1.08B.
  • Eli Lilly made up 0.78% of Diamant Asset Management's portfolio in Q1 2026, its #27 holding.
  • Diamant Asset Management first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Diamant Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.